Overview Efficacy and Safety of Tocilizumab for TAO Status: Withdrawn Trial end date: 2023-09-23 Target enrollment: Participant gender: Summary This study aims to evaluate the efficacy and safety of tocilizumab treating Thyroid Associated Ophthalmopathy. Phase: Phase 2 Details Lead Sponsor: Sun Yat-sen University